Muneyuki Masuda - Publications

Prognostic impact of immune-related adverse events in recurrent or metastatic sinonasal squamous cell carcinoma treated with immune checkpoint inhibitors.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: March 03, 2026

Aberrant Hippo-YAP/TEAD Signaling Drives Malignant Transcriptional Reprogramming in External Auditory Canal Squamous Cell Carcinoma.

Journal: Cancer research communications

Published: October 14, 2025

Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer.

Journal: Oral oncology

Published: April 23, 2025

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Journal: JAMA

Published: March 13, 2025

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).

Journal: Frontiers in immunology

Published: July 14, 2024

Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation.

Journal: Cancers

Published: June 20, 2024

Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.

Journal: PloS one

Published: May 09, 2024

Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma.

Journal: Frontiers in immunology

Published: February 24, 2024

Acquired tracheobronchomalacia developed following voice prosthesis implantation.

Journal: Auris, nasus, larynx

Published: September 15, 2023

Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.

Journal: Head & neck

Published: August 01, 2023

A novel approach to predict acute radiation dermatitis in patients with head and neck cancer using a model based on Bayesian probability.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: June 19, 2023

Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.

Journal: In vivo (Athens, Greece)

Published: May 08, 2023